Cosmos Health Enters into Binding Letter of Intent for the Acquisition of Docpharm GmbH., an Established German Pharmaceutical Distributor; Expected to Boost Our Annual Revenue by Approximately Euro32M, or 70%, by the End of 2025 vs FY 2022. May 25, 2023
The Alkaline Water Company to Attend LD Micro Invitational XIII as Official Water Sponsor May 24, 2023
AXIM Biotechnologies Announces Over 40 Initial Clinic Commitments for Its Full Diagnostic Assay Platform Launch May 24, 2023